Resolute Advisors’s Clorox CLX Stock Holding History

Resolute Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-48	Closed	-$8K	–	249
2021 Q3	$8K	Hold	48	–	–	﹤0.01%	373
2021 Q2	$9K	Hold	48	–	–	﹤0.01%	294
2021 Q1	$9K	Buy	+48	New	+$9.24K	﹤0.01%	238

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Resolute Advisors's CLX Position: Q4 2021 in Review

Resolute Advisors sold out of Clorox (CLX) in Q4 2021, closing a stake of 48 shares — an estimated $8K sold.

Resolute Advisors first reported a position in CLX in Q1 2021 and held it in 3 quarters. The position peaked at $9K in Q2 2021. 1,219 funds tracked by Wall St. Rank hold CLX as of Q4 2021.

Resolute Advisors reported no remaining Clorox position as of Q4 2021 after selling out during the quarter.
Resolute Advisors sold 48 Clorox shares in Q4 2021, an estimated $8K.
Resolute Advisors first reported a position in Clorox in Q1 2021 and held it in 3 quarters.
Resolute Advisors's Clorox position peaked at $9K in Q2 2021.
1,219 funds tracked by Wall St. Rank held Clorox as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.